AKT1 and non-small cell lung carcinoma: Interestingly, circFGFR3 has been reported to enhance galectin‐1 expression by competitively binding to miR‐22‐3p, thereby activating the AKT and ERK pathways to promote the proliferation and invasion of NSCLC cells.273